(Q44138324)

English

Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eastern Cooperative Oncology Group

6

object named as

Eastern Cooperative Oncology Group

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

David S Ettinger

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dianne M Finkelstein

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Paul S Ritch

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sarah T Lincoln

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ronald H Blum

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

37

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

311-318

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Current status of etoposide in the management of small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900074-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(02)00074-0

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44138324&oldid=2107014285"